Go Pro

California Public Employees Retirement System Trims Stock Position in Ventas, Inc. $VTR

Ventas logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • California Public Employees Retirement System cut its Ventas stake by 10.4% in the first quarter, though it still held about 1.09 million shares valued at roughly $88.8 million.
  • Ventas reported Q1 earnings of $0.11 per share, missing analyst expectations by a penny, but revenue came in above estimates at $1.65 billion and rose 22% year over year.
  • The company recently paid a quarterly dividend of $0.52 per share, equal to an annualized yield of 2.2%, while Wall Street largely remains positive with a consensus rating of Moderate Buy and an average target price of $96.17.
  • MarketBeat previews the top five stocks to own by August 1st.

California Public Employees Retirement System trimmed its stake in shares of Ventas, Inc. (NYSE:VTR - Free Report) by 10.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,086,136 shares of the real estate investment trust's stock after selling 126,474 shares during the quarter. California Public Employees Retirement System owned about 0.22% of Ventas worth $88,824,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. GoalVest Advisory LLC acquired a new position in shares of Ventas in the fourth quarter valued at approximately $26,000. Wiser Advisor Group LLC purchased a new stake in shares of Ventas during the third quarter worth approximately $27,000. IFC & Insurance Marketing Inc. purchased a new stake in shares of Ventas during the fourth quarter worth approximately $30,000. Elyxium Wealth LLC acquired a new stake in shares of Ventas during the fourth quarter worth $33,000. Finally, Reflection Asset Management acquired a new stake in shares of Ventas during the fourth quarter worth $34,000. 94.18% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Ventas

In related news, Director Michael J. Embler purchased 2,500 shares of the stock in a transaction dated Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares of the company's stock, valued at $2,557,079.80. This represents a 3.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by insiders.

Ventas Stock Up 0.0%

VTR opened at $96.14 on Monday. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. The business has a 50 day simple moving average of $87.26 and a 200-day simple moving average of $84.19. The stock has a market capitalization of $46.74 billion, a P/E ratio of 174.81, a P/E/G ratio of 2.07 and a beta of 0.70. Ventas, Inc. has a 12 month low of $65.15 and a 12 month high of $97.16.

Ventas (NYSE:VTR - Get Free Report) last announced its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the company earned $0.84 EPS. The company's revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities analysts anticipate that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.

Ventas Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Tuesday, June 30th. Ventas's payout ratio is presently 378.18%.

Wall Street Analyst Weigh In

VTR has been the topic of a number of analyst reports. BMO Capital Markets reiterated an "outperform" rating and issued a $100.00 price objective on shares of Ventas in a research report on Monday, May 4th. Mizuho set a $98.00 price objective on shares of Ventas in a research report on Friday, May 22nd. JPMorgan Chase & Co. raised their target price on shares of Ventas from $93.00 to $94.00 and gave the stock an "overweight" rating in a research note on Monday, May 11th. KeyCorp lifted their target price on shares of Ventas from $90.00 to $95.00 and gave the company an "overweight" rating in a report on Thursday, May 7th. Finally, Jefferies Financial Group boosted their price target on shares of Ventas from $97.00 to $100.00 and gave the stock a "buy" rating in a research note on Tuesday, May 12th. Fourteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $96.17.

Read Our Latest Stock Analysis on VTR

Ventas Company Profile

(Free Report)

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Further Reading

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ventas Right Now?

Before you consider Ventas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.

While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines